Jubilant Generics Limited — Azithromycin Exporter Profile
Indian Pharmaceutical Exporter · #6 for Azithromycin · $6.9M export value · DGFT Verified
Jubilant Generics Limited is the #6 Indian exporter of Azithromycin with $6.9M in export value and 164 verified shipments. Jubilant Generics Limited holds a 3.8% market share in Azithromycin exports across 14 countries. The company exports 6 pharmaceutical products worth $23.9M across 4 therapeutic categories.
Jubilant Generics Limited — Azithromycin Export Profile: Buyers & Destinations
Where Does Jubilant Generics Limited Export Azithromycin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| SOUTH AFRICA | $1.5M | 34 | 23.7% |
| UNITED KINGDOM | $1.5M | 48 | 23.3% |
| UNITED ARAB EMIRATES | $1.1M | 49 | 17.8% |
| ALGERIA | $750.0K | 15 | 11.8% |
| ISRAEL | $348.8K | 9 | 5.5% |
| BELGIUM | $289.0K | 19 | 4.5% |
| MALAYSIA | $224.3K | 13 | 3.5% |
| FINLAND | $165.5K | 4 | 2.6% |
| ZIMBABWE | $157.1K | 7 | 2.5% |
| BOTSWANA | $131.3K | 3 | 2.1% |
Jubilant Generics Limited exports Azithromycin to 15 countries. The largest destination is SOUTH AFRICA accounting for 23.7% of Jubilant Generics Limited's Azithromycin shipments, followed by UNITED KINGDOM (23.3%) and UNITED ARAB EMIRATES (17.8%). These destinations reflect Jubilant Generics Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Azithromycin from Jubilant Generics Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| ELARA PHARMASERVICES LIMITED | UNITED KINGDOM | $1.1M | 33 |
| BETA STAR TRADING LLC | UNITED ARAB EMIRATES | $706.0K | 20 |
| UNICORN PHARMACEUTICALS (PTY)LTD | SOUTH AFRICA | $500.0K | 10 |
| HOUSING BANK ALGERIE | ALGERIA | $350.0K | 7 |
| UNICORN PHARMACEUTICALS (PTY) LTD | SOUTH AFRICA | $334.9K | 7 |
| ELARA PHARMA SERVICES LIMITED | UNITED KINGDOM | $317.6K | 14 |
| INOVAMED LTD | ISRAEL | $249.1K | 5 |
| YUSEN LOGISTICS BENELUX | BELGIUM | $221.3K | 8 |
| JUBILANT PHARMA SA (PTY) LIMITED | SOUTH AFRICA | $210.6K | 5 |
| UNICORN PHARMACEUTICALS PTY LTD | SOUTH AFRICA | $182.6K | 4 |
Jubilant Generics Limited supplies Azithromycin to 47 buyers globally. The largest buyer is ELARA PHARMASERVICES LIMITED (UNITED KINGDOM), followed by BETA STAR TRADING LLC (UNITED ARAB EMIRATES) and UNICORN PHARMACEUTICALS (PTY)LTD (SOUTH AFRICA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Azithromycin Export Value and How Much Does Jubilant Generics Limited Contribute?
India exported $74.0M worth of Azithromycin through 15,000 shipments from 853 suppliers to 169 countries, serving 2,397 buyers globally. Jubilant Generics Limited contributes $6.9M to this total, accounting for 3.8% of India's Azithromycin exports. Jubilant Generics Limited ships Azithromycin to 15 countries through 47 buyers.
What Is the Average Shipment Value for Jubilant Generics Limited's Azithromycin Exports?
Jubilant Generics Limited's average Azithromycin shipment value is $42.2K per consignment, based on 164 shipments totaling $6.9M. The largest destination is SOUTH AFRICA (23.7% of Jubilant Generics Limited's Azithromycin exports).
How Does Jubilant Generics Limited Compare to Other Indian Azithromycin Exporters?
Jubilant Generics Limited ranks #6 among 853 Indian Azithromycin exporters with a 3.8% market share. The top 3 exporters are LUPIN LIMITED ($11.0M), ALEMBIC PHARMACEUTICALS LIMITED ($8.7M), CIPLA LIMITED ($8.4M). Jubilant Generics Limited processed 164 shipments to 14 destination countries.
What Azithromycin Formulations Does Jubilant Generics Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| AZITHROMYCIN DC GRANULES 55.56% BATCH NO | $200.0K | 4 |
| AZITHROMYCIN 500MG FCT 1X3 S UNICORNSAFR | $184.9K | 4 |
| AZITHROMYCIN 500MG (AZIJUB-500MG)B.NO.AZ | $173.9K | 4 |
| AZITHROMYCIN 500MG FCT 1x3's UNICORNSAFR | $150.0K | 3 |
| AZITHROMYCIN 500MG FCT 1X3'S UNICORNSAFR | $150.0K | 3 |
| AZITHROMYCIN 500MG FCT 1X3'S UNICORN SAF | $150.0K | 3 |
| AZITHROMYCIN 500MG FCT 1X3'S UNICORNSAFR(AZITHROMYCIN 500 MG FILM COATED TABLETS) B/N:AZ225007B MD:02/25 ED:01/27 | $150.0K | 3 |
| AZITHROMYCIN 500MG FCT 1X3'S UNICORNSAFR(AZITHROMYCIN 500 MG FILM COATED TABLETS) B/N:AZ225004C MD:02/25 ED:01/27 | $150.0K | 3 |
| AZITHROMYCIN DC GRANULES 55.56 B/N: AZ02 | $100.0K | 2 |
| AZITHROMYCIN 250 MG FCT 2X3, BATCH NO.AZ | $100.0K | 2 |
Jubilant Generics Limited exports 156 distinct Azithromycin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is AZITHROMYCIN DC GRANULES 55.56% BATCH NO with 4 shipments worth $200.0K.
Regulatory Requirements: Exporting Azithromycin to Key Markets
What Jubilant Generics Limited must comply with to export Azithromycin to its top destination countries
South Africa — SAHPRA
Approval Process
Registration under SAHPRA guidelines (CTD format). Bioequivalence required for generics.
Timeline: 24–48 months (significant backlog)
GMP & Export Requirements
WHO GMP or PIC/S GMP compliance
Certificate of Pharmaceutical Product from CDSCO; Import permit per Section 22A of Medicines Act
Note: Known registration backlog. WHO Prequalification significantly assists the process.
United Kingdom — MHRA
Approval Process
Post-Brexit UK Marketing Authorisation via national procedure. Separate from EU approval since January 2021.
Timeline: 12–15 months
GMP & Export Requirements
UK GMP compliance; MHRA inspection of manufacturing site
Manufacturer Import Authorisation (MIA) held by UK importer; Qualified Person (QP) batch release
Note: Post-Brexit: EU GMP certificates no longer automatically valid in UK. Separate MHRA recognition required.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Jubilant Generics Limited Compare to Nearest Azithromycin Exporters?
Exporters ranked immediately above and below #6 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 4 | ALEMBIC PHARMACEUTICALS LIMITED | $8.7M | 174 | 2 | $50.0K |
| 5 | CIPLA LIMITED | $8.4M | 208 | 12 | $40.3K |
| 6 | JUBILANT GENERICS LIMITED ★ | $6.9M | 164 | 14 | $42.2K |
| 7 | ZYDUS LIFESCIENCES LIMITED | $6.0M | 161 | 8 | $37.3K |
| 8 | AJANTA PHARMA LIMITED | $5.8M | 278 | 20 | $21.0K |
Jubilant Generics Limited ranks #6 among 853 Indian Azithromycin exporters. Average shipment value of $42.2K compared to the market average of $86.8K. The closest competitors by value are ALEMBIC PHARMACEUTICALS LIMITED and CIPLA LIMITED.
Which Indian Ports Ship Azithromycin Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 2,394 | 16.0% |
| SAHAR AIR | 2,211 | 14.7% |
| DELHI AIR CARGO ACC (INDEL4) | 1,693 | 11.3% |
| DELHI AIR | 1,106 | 7.4% |
| JNPT/ NHAVA SHEVA SEA | 902 | 6.0% |
| NHAVA SHEVA SEA (INNSA1) | 870 | 5.8% |
| Bombay Air | 618 | 4.1% |
| JNPT | 408 | 2.7% |
Geopolitical & Trade Policy Impact on Jubilant Generics Limited's Azithromycin Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Jubilant Generics. The Israel-Iran conflict has led to disruptions in Red Sea shipping routes, causing increased freight charges and potential losses estimated between ₹2,500 crore to ₹5,000 crore in March 2026. These disruptions have particularly impacted exports to the Middle East, a key market for Indian pharmaceuticals. (fortuneindia.com)
Conversely, U.S.-China trade tensions have opened avenues for Indian exporters to capture a larger share of the U.S. market. However, recent U.S. tariffs on imports, including pharmaceuticals, pose a risk to this opportunity. The Federation of Indian Export Organisations highlighted that these tariffs could affect nearly 55% of India's exports to the U.S., potentially leading to the loss of longstanding clients. (apnews.com)
In the European Union, compliance with the Falsified Medicines Directive (FMD) remains a critical requirement. Indian exporters must invest in serialization and traceability systems to meet these stringent regulations, ensuring continued access to the EU market.
Jubilant Generics Limited — Regulatory Compliance & Quality Standards
Maintaining compliance with international regulatory standards is paramount for Jubilant Generics. The company's Roorkee facility's VAI classification by the USFDA in 2024 reflects its adherence to current good manufacturing practices. (business-standard.com) However, the Indian pharmaceutical industry faces ongoing scrutiny regarding quality and compliance. In 2023, the USFDA conducted over 200 inspections in India, with plans to increase this number in 2024, underscoring the need for continuous quality assurance. (fact.net.in)
Additionally, the company has faced legal challenges concerning intellectual property. In March 2025, a court in Uttar Pradesh restrained Jamp Pharma from using Jubilant Generics' confidential data, granting an injunction against copyright infringement. (scconline.com) This case highlights the importance of safeguarding proprietary information in the competitive pharmaceutical landscape.
About Jubilant Generics Limited
Jubilant Generics Limited exports 6 products worth $23.9M. Beyond Azithromycin, top products include Atorvastatin, Esomeprazole, Valsartan, Irbesartan, Valacyclovir. View the complete Jubilant Generics Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Azithromycin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Azithromycin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Jubilant Generics Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 212 individual customs records matching Jubilant Generics Limited exporting Azithromycin, covering 156 formulations to 15 countries via 47 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 169+ countries, 2,397+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Azithromycin Export Data from Jubilant Generics Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Jubilant Generics Limited's Azithromycin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Jubilant Generics Limited
Full Company Profile →
6 products · $23.9M total trade · 4 categories
Azithromycin Stats
Company Overview
Top Products by Jubilant Generics Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Jubilant Generics Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Azithromycin. For current shipment-level data, contact TransData Nexus.